Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Standard Biotools (LAB) Asset Writedowns and Impairment (2019)

Historic Asset Writedowns and Impairment for Standard Biotools (LAB) over the last 1 years, with Q4 2019 value amounting to $400000.0.

  • Standard Biotools' Asset Writedowns and Impairment changed N/A to $400000.0 in Q4 2019 from the same period last year, while for Sep 2022 it was $400000.0, marking a year-over-year change of. This contributed to the annual value of $3.5 million for FY2022, which is N/A changed from last year.
  • Standard Biotools' Asset Writedowns and Impairment amounted to $400000.0 in Q4 2019.
  • Over the past 5 years, Standard Biotools' Asset Writedowns and Impairment peaked at $400000.0 during Q4 2019, and registered a low of $400000.0 during Q4 2019.